• Kalyani K. Jadhav
• Avitashri S. Patil
• Mrunal S. Bhosale
• Indrayani D. Raut
• Mangesh A. Bhutkar

The liposomes,sphere-shaped aqueous vesicles consisting of one or more concentric lipid bilayers.They are mainly made up of phospholipids. Liposomes made with phospholipids identical to natural lung surfactant (Dipalmitoylphosphadylcholine)and lipids offers biocompatibility and versality in the field of pulmonary medicine, treating disorders like lung cancer,cystic fibrosis, lung infections etc.Improved pharmacokinetics with lower toxicity,higher therapeutic efficiency,increased distribution of poorly soluble medicines,and taste masking,sustained drug release, targeted drug delivery are all advantages of liposomal pulmonary drug delivery. Because of the lung's large absorptive surface area,high permeability (above 70-140m2),low protective activity and enough blood supply.pulmonary route is today considered as one of the most successful drug delivery systems. Liposomal pulmonary carrier has also been used for systemic distribution of drugs like insulin,human growth hormone, and calcitonin. There are different types of inhalation devices like pressurized metered dose inhale, soft mist inhaler,dry power inhaler,Nebulizer etc. are used.This review provides an overview of liposomal pulmonary drug delivery system.

Liposome, Phospholipids, Sustained Drug Release, Targeted Drug Delivery Pulmonary Drug Delivery Carrier.

"Liposomes: A Promising Pulmonary Drug Delivery Carrier", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 8, page no.f509-f518, August-2022, Available :http://www.jetir.org/papers/JETIR2208553.pdf

"Liposomes: A Promising Pulmonary Drug Delivery Carrier", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 8, page no. ppf509-f518, August-2022, Available at : http://www.jetir.org/papers/JETIR2208553.pdf